tacrine has been researched along with Vascular Diseases in 1 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samadi, A | 1 |
| Valderas, C | 1 |
| de los Ríos, C | 1 |
| Bastida, A | 1 |
| Chioua, M | 1 |
| González-Lafuente, L | 1 |
| Colmena, I | 1 |
| Gandía, L | 1 |
| Romero, A | 1 |
| Del Barrio, L | 1 |
| Martín-de-Saavedra, MD | 1 |
| López, MG | 1 |
| Villarroya, M | 1 |
| Marco-Contelles, J | 1 |
1 other study available for tacrine and Vascular Diseases
| Article | Year |
|---|---|
Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles.
Topics: Acetylcholinesterase; Alzheimer Disease; Cell Line, Tumor; Cholinesterase Inhibitors; Humans; Kineti | 2011 |